|
Volumn 22, Issue 5, 2014, Pages 1529-1538
|
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors
|
Author keywords
1,2 Dihydrobenzo d isothiazol 3 one 1,1 dioxide; Antiproliferative; Histone deacetylase inhibitor
|
Indexed keywords
1,2 DIHYDROBENZO[D]ISOTHIAZOL 3 ONE 1,1 DIOXIDE HYDROXAMIC ACID DERIVATIVE;
2 (1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)ACETIC ACID;
2 (6 NITRO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)ACETIC ACID;
3 (1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)PROPANOIC ACID;
3 (6 NITRO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL)PROPANOIC ACID;
3 [1,1 DIOXIDO 3 OXO 6 (3,4,5TRIMETHOXYBENZAMIDO)[D]ISOTHIAZOL 2(3H)YL]PROPANOIC ACID;
3 [6 [(1,10 BIPHENYL) 4 YLCARBOXAMIDO] 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]PROPANOIC ACID;
4 (1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)BUTANOIC ACID;
4 (6 NITRO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)BUTANOIC ACID;
5 (1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)PENTANOIC ACID;
5 (6 NITRO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)PENTANOIC ACID;
5 [6 BENZAMIDO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]PENTANOIC ACID;
6 (1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)HEXANOIC ACID;
6 (6 IODO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)HEXANOIC ACID;
6 (6 NITRO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H) YL)HEXANOIC ACID;
6 [1,1 DIOXIDO 3 OXO 6 (3,4,5 TRIMETHOXYBENZAMIDO)BENZO[D]ISOTHIAZOL 2(3H)YL]HEXANOIC ACID;
6 [6 (4 IODOBENZAMIDO) 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]HEXANOIC ACID;
6 [6 (4 METHOXYBENZAMIDO) 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]HEXANOIC ACID;
6 [6 [(1,10 BIPHENYL) 4 YLCARBOXAMIDO] 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]HEXANOIC ACID;
6 [6 BENZAMIDO 1,1 DIOXIDO 3 OXOBENZO[D]ISOTHIAZOL 2(3H)YL]HEXANOIC ACID;
ANTINEOPLASTIC AGENT;
HISTONE DEACETYLASE;
HISTONE DEACETYLASE INHIBITOR;
HYDROXAMIC ACID DERIVATIVE;
N [2 [6 (HYDROXYAMINO) 6 OXOHEXYL] 1,1 DIOXIDO 3 OXO 2,3 DIHYDROBENZO[D]ISOTHIAZOL 6 YL] 4 NITROBENZAMIDE;
N [2 [6 (HYDROXYAMINO) 6 OXOHEXYL] 1,1 DIOXIDO 3 OXO 2,3 DIHYDROBENZO[D]ISOTHIAZOL 6 YL]BENZAMIDE;
N [2 [6 (HYDROXYAMINO) 6 OXOHEXYL] 1,1 DIOXIDO 3 OXO 2,3 DIHYDROBENZO[D]ISOTHIAZOL 6 YL]THIOPHENE 2 CARBOXAMIDE;
SACCHARIN HYDROXAMIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VORINOSTAT;
HYDROXAMIC ACID;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
CELL PROLIFERATION;
CHEMISTRY;
METABOLISM;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
CELL PROLIFERATION;
DRUG DESIGN;
HISTONE DEACETYLASE INHIBITORS;
HISTONE DEACETYLASES;
HYDROXAMIC ACIDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84896706991
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2014.01.045 Document Type: Article |
Times cited : (17)
|
References (17)
|